• June 10, 2022  

    NCI Overview of Uterine Cancer Bookmark

    George Lundberg, MD

    The National Cancer Institute provides this online overview of uterine cancer that is up-to date, comprehensive, and written specifically for patients.

    .

  • June 10, 2022  

    NCCN Guidelines for Patients: Endometrial Cancer Bookmark

    George Lundberg, MD

    Endometrial cancer is the most common kind of uterine cancer. The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their most recent guideline for people with endometrial cancer.

    .

  • April 26, 2022  

    Can Immunotherapy Be Effective for Brain Cancer?

    With: Matt Warner, PhD

    Immunotherapy has reshaped the cancer treatment landscape. This type of treatment boosts the immune system to fight cancer. However, for people with advanced brain cancer, immunotherapy options remain slim. Here, our Curious Dr. George asks Cancer Commons Scientist Matt Warner, PhD, about the challenges and future potential of immunotherapy for brain cancer. Curious Dr. George: An accomplished molecular oncologist, you have now helped many… Read more »

  • April 20, 2022  

    Triplet Combination Improves Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer Bookmark

    George Lundberg, MD

    Metastatic carcinoma of the prostate is fatal, but a 3-drug combination treatment can prolong life substantially, according to new clinical trial results outlined by The ASCO Post.

    .

  • April 6, 2022  

    Essential Breast Cancer Treatment Trends in 2022: Webinar Highlights

    Sarah Stanley

    Women with breast cancer often face an overwhelming amount of information to sort through and decisions to make. Whether newly diagnosed or starting a next step in treatment, they may wonder: What does the latest research say about my type of breast cancer? Should I enroll in a clinical trial? How do I know if I’m receiving my best-possible treatment? Every day, Cancer Commons… Read more »

  • March 8, 2022  

    Hepatocellular Carcinoma in 2021: An Exhaustive Update Bookmark

    George Lundberg, MD

    This exhaustive scientific review was published by Cureus in 2021, but remains relevant now. It explores current molecular understanding of hepatocellular carcinoma—the most common type of cancer that starts in the liver—as well as a very large range of diagnostic and treatment options. 

    .

  • February 18, 2022  

    Palliative Care Options for a Young Adult Patient with a Diffuse Intrinsic Pontine Glioma Bookmark

    George Lundberg, MD

    This clinical case study published in the scientific journal Cureus suggests that intelligent, compassionate, palliative care is likely the best approach to this very difficult brain tumor.

    .

  • February 18, 2022  

    Chemotherapy: Before Surgery Vs. After Surgery Bookmark

    George Lundberg, MD

    According to this article from the Cochrane Database of Systematic Reviews, chemotherapy administered before surgery may be beneficial for people with advanced ovarian cancer.

    .

  • February 18, 2022  

    This New Ovarian Cancer Treatment Could Improve Survival Rates Bookmark

    George Lundberg, MD

    Recently approved by the U.S. Food and Drug Administration (FDA), the drug Cytalux is given to ovarian cancer patients to allow surgeons to recognize cancer cells more clearly, promoting more complete surgical removal of tumors. Learn more in this story from The Philadelphia Inquirer.

    .

  • February 8, 2022  

    Facing Esophageal Cancer in 2022

    Kaumudi Bhawe, PhD

    Difficulty swallowing, a hoarse voice, or heartburn has led to the dreaded diagnosis of esophageal cancer. What now? Origin, Types, and Stages of Esophageal Cancer If you or a loved one face esophageal cancer, it can be helpful to start by learning more about the disease and your particular diagnosis. Then, you will be prepared to learn about esophageal cancer treatments. Esophageal cancer originates… Read more »